Louisbourg Investments Inc. Charles River Laboratories International, Inc. Transaction History
Louisbourg Investments Inc.
- $368 Billion
- Q1 2025
A detailed history of Louisbourg Investments Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Louisbourg Investments Inc. holds 10 shares of CRL stock, worth $1,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$1,186% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
700Shares Held
50.6MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$731 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$604 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$259 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$214 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$211 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.03B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...